TAG:
lab test
HPV Test Volume Grows With Payer Acceptance
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
CEO SUMMARY: Because cervical cancer screening involves more than 55 million Pap tests per year in the United States, it is a high-profile segment of the lab testing industry. HPV testing is making steady inroads into the cervical cancer screening process. Digene Corporation is the direct…
Specialty Laboratories, Enterix, Medicare, Blue Cross/Blue Shield Association
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
SPECIALTY LABORATORIES REPORTS THIRD QUARTER FINANCIAL PERFORMANCE THIRD QUARTER FINANCIAL REPORTS for Specialty Laboratories, Inc. show that the company is returning to a more normal routine, following the two unusual and unrelated events which hit it during 2002. Special…
Mergers Create Two Huge National Health Insurers
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
ANOTHER ROUND OF CONSOLIDATION among health insurers has created a new “biggest in the nation” company and boosted the size of the second largest health insurance company. On October 28, in separate announcements that were just 30 minutes apart, Anthem Inc. disclosed it would pa…
“November 10, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
Has the disappearance of much despised closed panel HMOs eased the financial woes of physicians? Apparently not, according to a recent study. Medical groups are losing money. Nationwide, the average loss-per-physician by medical groups was $3,977. In the 2003 survey, 25,784 physicians responded, a 26…
OIG Moves to Address “Usual Charge” Issue
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
CEO SUMMARY: Federal regulators are taking another crack at defining “usual charges.” Language in the proposed rules published last month precisely defines which payers should be included in determining “usual charges” and what charge basis to use for specific payers. Once effecti…
Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
CEO SUMMARY: This exclusive intelligence briefing predicts how specific new technologies may drive changes in the laboratory-testing marketplace during the next five years. The key message is that change is expected to be incremental, not disruptive—given the technology known to be in d…
Two Blood Brothers Ramp Up Marketing of New Lab Assays
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
GROWTH IN SPECIMEN VOLUME and revenues is the major challenge at the nation’s two largest laboratory corporations. How Laboratory Corporation of America and Quest Diagnostics Incorporated solve this problem will affect and influence every remaining clinical labora…
West Hills Lab Outreach Still Thrives in California
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: Now in its seventh year, the lab outreach program at West Hills Hospital and Medical Center in Southern California continues to produce significant revenues. The goal was to target physicians’ offices in the medical campus around the hospital and provide them a local laborato…
Brazil’s Lab Industry Gathers in Rio de Janeiro
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: Healthcare in Brazil remains a free market and thousands of clinical laboratories exist to fill the demand. However, there are early indications that commercial laboratories in Brazil may be on the verge of the same tidal wave of lab acquisitions and consolidation that was ex…
“September 29, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
There was cautious optimism among lab industry leaders lobbying Congress to stop the proposed 20% co- payment for Part B laboratory testing services. It seems that, over the summer break, Iowa Senator Charles Grassley got a lesson in grass roots lobbying. At a number of town meetings, irate seniors s…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized